Diabetes, Vol 40, Issue 4 509-515, Copyright © 1991 by American Diabetes Association

ARTICLES

Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. San Luis Valley Diabetes Study

EJ Boyko, EM Keane, JA Marshall and RF Hamman
Department of Medicine, University of Washington, Seattle.

Hyperinsulinemia has been demonstrated in Hispanics with normal glucose tolerance and in other populations at higher risk for non-insulin-dependent diabetes mellitus (NIDDM). We compared fasting and glucose-stimulated insulin and C-peptide levels in a community-based sample of 464 Hispanic and 676 non-Hispanic white adult residents of the San Luis Valley of Colorado. All subjects had normal glucose tolerance as confirmed by oral glucose tolerance testing interpreted with World Health Organization criteria. Mean fasting and 1- and 2-h post-glucose load insulin levels were significantly higher in Hispanics versus non-Hispanic whites (fasting 0.08 vs. 0.07 nM, P = 0.0026; 1 h 0.52 vs. 0.47 nM, P = 0.0129; 2 h 0.36 vs. 0.27 nM, P less than 0.0001), even after adjustment for age, sex, body mass index, waist-hip ratio, family history of diabetes mellitus, concurrent plasma glucose level, and fasting insulin level. Mean fasting and 1- and 2-h glucose-stimulated C-peptide levels in Hispanics also significantly exceeded those in non-Hispanic whites (fasting 0.58 vs. 0.54 nM, P = 0.0119; 1 h 2.72 vs. 2.46 nM, P less than 0.0001; 2 h 2.25 vs. 1.97 nM, P less than 0.0001). The C-peptide-insulin molar ratio was greater in non-Hispanic whites than Hispanics at all times measured. These findings confirm that Hispanics with normal glucose tolerance are hyperinsulinemic and that increased insulin secretion is at least partly responsible for this phenomenon. The lower levels of C-peptide compared with insulin in Hispanics suggest that the hyperinsulinemia seen in this ethnic group may be due in part to decreased hepatic insulin extraction.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Schuster, T. Gaillard, S. Rhinesmith, D. Habash, and K. Osei Impact of Metformin on Glucose Metabolism in Nondiabetic, Obese African Americans: A placebo-controlled, 24-month randomized study Diabetes Care, November 1, 2004; 27(11): 2768 - 2769. [Full Text] [PDF]

				J. I. Torrens, J. Skurnick, A. L. Davidow, S. G. Korenman, N. Santoro, M. Soto-Greene, N. Lasser, and G. Weiss Ethnic Differences in Insulin Sensitivity and {beta}-Cell Function in Premenopausal or Early Perimenopausal Women Without Diabetes: The Study of Women's Health Across the Nation (SWAN) Diabetes Care, February 1, 2004; 27(2): 354 - 361. [Abstract] [Full Text] [PDF]

				C. C. Jensen, M. Cnop, R. L. Hull, W. Y. Fujimoto, S. E. Kahn, and the American Diabetes Association GENNID Study Gro {beta}-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes, July 1, 2002; 51(7): 2170 - 2178. [Abstract] [Full Text] [PDF]

				M. A. Winkleby, T. N. Robinson, J. Sundquist, and H. C. Kraemer Ethnic Variation in Cardiovascular Disease Risk Factors Among Children and Young Adults: Findings From the Third National Health and Nutrition Examination Survey, 1988-1994 JAMA, March 17, 1999; 281(11): 1006 - 1013. [Abstract] [Full Text] [PDF]

				M. A. Winkleby, H. C. Kraemer, D. K. Ahn, and A. N. Varady Ethnic and Socioeconomic Differences in Cardiovascular Disease Risk Factors: Findings for Women From the Third National Health and Nutrition Examination Survey, 1988-1994 JAMA, July 22, 1998; 280(4): 356 - 362. [Abstract] [Full Text] [PDF]